Hernia mesh, a medical device commonly used in hernia repair surgeries, has recently become a subject of concern due to numerous reports of complications and adverse effects. In this informative landing page, we aim to shed light on hernia mesh, its purpose, and the reasons why individuals have been reporting problems associated with its use.
Hernia mesh is a surgical implant made of synthetic materials such as polypropylene or composite materials. It is designed to reinforce weakened tissues and support the abdominal wall during hernia repair procedures. Surgeons often choose mesh implants due to their potential to reduce the risk of hernia recurrence and offer faster recovery times.
However, a significant number of patients have experienced unexpected and debilitating complications following hernia mesh surgery. These complications include chronic pain, infections, mesh erosion, adhesion formation, bowel obstructions, and even perforation of surrounding organs. Such complications can have a profound impact on a person’s quality of life, requiring additional surgeries, prolonged medical treatments, and leading to significant physical, emotional, and financial burdens.
The reported problems with hernia mesh have been linked to various factors, including defective mesh design, inadequate manufacturing processes, and improper surgical techniques. The complexity of these cases has prompted affected individuals to seek legal action against the manufacturers of hernia mesh implants, aiming to hold them accountable for their negligence and pursue rightful compensation.
The hernia mesh lawsuit refers to a legal action taken by individuals who have experienced complications or injuries as a result of surgical mesh used in hernia repair procedures, alleging that the mesh products were defective and the manufacturers failed to provide adequate warnings or instructions.
Experiencing a failed hernia mesh surgery can be a distressing and challenging ordeal. Initially, the patient undergoes hernia repair surgery, during which a mesh is implanted to reinforce the weakened or torn abdominal wall. However, in cases where the mesh fails, the consequences can be severe. The failure may manifest in various ways, such as mesh erosion, migration, or shrinkage, leading to chronic pain, infections, bowel obstruction, or recurrence of the hernia.
Following a failed hernia mesh surgery, the patient typically experiences physical discomfort and emotional distress. They may endure persistent pain at the surgical site, which can radiate to surrounding areas. In addition to the physical symptoms, the individual may face limitations in their daily activities, decreased quality of life, and a need for further medical intervention. Seeking prompt medical attention and consulting with a healthcare professional experienced in hernia mesh complications are crucial steps in addressing the situation and exploring possible corrective measures.
In order to be eligible to file this lawsuit, there are a few qualifying factors that must be met. To ensure that you qualify, we recommend that you work with an experienced hernia mesh lawyer to increase your chances of a settlement. Some eligibility factors include:
The third Bellwether trial in the Bard Hernia Mesh lawsuit, Stinson v. Bard, is set for October 16th, 2023. After being delayed in May, 2023, this trial will serve as focal point for the entire litigation.
Bard argues that Stinson is not elligible to go to trial. Due to the worsening conditions of the plaintiff’s injuries, Bard contests that these injuries have escalates past the point of a good bellwether trial.
This tactic aligns with Bard’s desire to prolong the process, which allows them to hold on to their capital for as long as possible. This tactic is an attempt to persuade plaintiffs to settle for less than what they deserve.
The MDL remains open despite a confidential settlement in Spetember, 2021.
Judge Granted a Motion to Establish Qualified Settlement Fund in the Atrium MDL. The settlement terms are undisclosed, but the Swedish parent company, Getinge Group, has announced that they will set aside over $66 million to resolve pending lawsuits.
A jury in Rhode Island court returned a $4.8 Million plaintiff verdict for Paul Trevino, who was implanted with a Bard Ventralex hernia patch system in 2008.